RVNC DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on March 4, 2025

1 week ago 1

NEW YORK - January 11, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a people enactment suit has been filed against Revance Therapeutics (NASDAQ:), Inc. (Revance oregon the Company) (NASDAQ: RVNC) connected behalf of investors that purchased oregon different acquired Revance securities betwixt February 29, 2024 and December 6, 2024 (the Class Period).

CLICK HERE TO JOIN THE CASE

If you are an capitalist successful Revance and person suffered losses, you whitethorn CLICK HERE to interaction us. You whitethorn besides interaction Kaplan Fox by emailing pmayer@kaplanfox.com oregon by calling (646) 315-9003.

DEADLINE REMINDER: If you are a subordinate of the projected Class, you whitethorn determination the tribunal nary aboriginal than March 4, 2025 to service arsenic a pb plaintiff for the purported class. If you person losses we promote you to interaction america to larn much astir the pb plaintiff process.

Revance is simply a biotechnology institution and the distributor of definite dermal filler products pursuant to an exclusive organisation statement with Teoxane SA.

On August 12, 2024, Revance issued a property merchandise announcing that the Company had entered into a merger statement with Crown Laboratories (Crown). Under the presumption of the agreement, the property merchandise indicated that Crown would commence a tender connection to get each outstanding shares of Revances communal banal for $6.66 per stock (the Tender Offer).

Then, connected September 23, 2024, Revance disclosed that it received a announcement to remedy alleged worldly breaches, including breaches of the maximum levels of buffer banal and required efforts to beforehand and merchantability Teoxane products, nether the Companys exclusive organisation statement with Teoxane SA. Due to the quality with Teoxane, the Company advised that Crowns Tender Offer had been delayed until astatine slightest October 4, 2024.

On this news, the terms of Revance banal fell $.445 per share, oregon 7.66%, to adjacent astatine $5.365 per stock connected September 23, 2024.

Then, connected December 9, 2024, the Company disclosed that Crown and Revance had amended their merger agreement, and that Crown would commence a tender connection connected December 12, 2024 to get each outstanding shares of Revance communal banal for $3.10 per share, much than 50% little than the archetypal acquisition price.

On this news, the terms of Revance banal fell $.79 per share, oregon 20.68%, to adjacent astatine $3.03 per stock connected December 9, 2024.

The ailment alleges, among different things, that passim the Class Period, Defendants made mendacious and/or misleading statements and/or failed to disclose that (i) Revance was successful worldly breach of the Distribution Agreement; (ii) the foregoing subjected the Company to an accrued hazard of litigation, arsenic good arsenic monetary and reputational harm; and (iii) each the foregoing accrued the hazard that the Tender Offer would beryllium delayed and/or amended.

WHY CONTACT KAPLAN FOX - Kaplan Fox is simply a starring nationalist instrumentality steadfast focusing connected analyzable litigation with offices successful New York, Oakland, Los Angeles, Chicago and New Jersey. With implicit 50 years of acquisition successful securities litigation, Kaplan Fox offers the nonrecreational acquisition and way grounds that clients demand. Through prosecuting cases connected the national and authorities levels, Kaplan Fox has successfully shaped the instrumentality done winning galore important decisions connected behalf of our clients. For much accusation astir Kaplan Fox & Kilsheimer LLP, you whitethorn sojourn our website astatine www.kaplanfox.com .

This property merchandise whitethorn beryllium considered Attorney Advertising successful immoderate jurisdictions nether the applicable instrumentality and ethical rules.

If you person immoderate questions astir this Notice, your rights, oregon your interests, delight contact:

CONTACT:

Pamela A. Mayer

KAPLAN FOX & KILSHEIMER LLP

800 Third Avenue, 38th Floor

New York, New York 10022

(646) 315-9003

pmayer@kaplanfox.com

Laurence D. King

KAPLAN FOX & KILSHEIMER LLP

1999 Harrison Street, Suite 1560

Oakland, California 94612